Pradaxa Lawsuit Claims Internal Bleeding Led to 10-Day Hospitalization By Andrea Gressman
Pradaxa Lawsuit Claims Internal Bleeding Led to 10-Day Hospitalization
By Andrea Gressman
Illinois resident John Colletta has filed a Pradaxa lawsuit against the drug’s manufacturer alleging that less than six months after taking the blood-thinning drug, he experienced internal bleeding that led to a 10-day hospitalization period. His Pradaxa internal bleeding lawsuit was added to the Pradaxa MDL.
Another Pradaxa Lawsuit Added to MDL
Colletta originally filed the Pradaxa internal bleeding lawsuit on August 27, 2012 in the Northern District of Illinois. However, it ended up in the U.S. District Court in Illinois’ Southern District, where it was added to other Pradaxa lawsuits in the consolidated MDL.
The whole reason behind multidistrict litigation is to combine Pradaxa lawsuits related to one another and to facilitate the judicial process’ efficient flow by bringing together similar findings and evidence. The Pradaxa lawsuit MDL was also put in place to determine which legal questions are common to all the Pradaxa lawsuits. In addition, it helps to avoid rulings that lack in consistency or that conflict with one another. An estimated 80 Pradaxa lawsuits exist in the Pradaxa multidistrict litigation. David R. Herndon, the judge, is overseeing the process.
The Pradaxa internal bleeding lawsuit indicated that Colletta had a Pradaxa prescription written by his doctor and commenced using the drug nearing the end of October 2012. Not even six months had passed when Colletta began to bleed internally as a result of the drug, which led to his hospitalization period. Colletta spent 10 days in the hospital trying to save his life from Pradaxa internal bleeding side effects. Colletta states that he lacked vital knowledge pertaining to Pradaxa’s potential dangers that would have deterred him from taking the drug.
The Pradaxa bleeding side effects lawsuit is claiming the following against the manufacturer:
* Product liability
* Criminal negligence
* Cause of personal injury
FDA Receives Reports of Hundreds of Pradaxa Bleeding Fatalities
Drug maker Boehringer Ingelheim Pharmaceuticals is on the receiving end of many Pradaxa lawsuits, including plaintiff Colletta’s, regarding internal bleeding injuries caused by Pradaxa. FDA reports state that many negative side effects have been linked to Pradaxa, including the deaths of over 500 people who have suffered internal bleeding as a direct result of Pradaxa.
Pradaxa is an anticoagulant designed to aid in preventing blood clots, which may lead to stokes in people suffering from atrial fibrillation. In 2010, the drug received approval from the FDA. Its main draw was its convenience, as it did not require strict diet regulations nor did it require patients to undergo frequent blood monitoring, as the alternative drug, warfarin does. Unlike Warfarin’s internal bleeding, which can be treated with a dose of Vitamin K, Pradaxa has no cure or treatment for its internal bleeding.
Pradaxa Bleeding Side Effects
Pradaxa has been linked to a number of side effects, including the following:
* Severe and uncontrollable intestinal bleeding
* Gastrointestinal bleeding
* Brain hemorrhage
* Kidney bleeding
* Internal bleeding
* Heart attack
* And even death
If you have experienced any of the side effects of Pradaxa listed above, including internal bleeding, gastrointestinal bleeding, brain hemorrhage, kidney bleeding, internal bleeding, heart attack, or even death and were also taking Pradaxa, visit the Pradaxa Internal Bleeding Class Action Lawsuit Investigation page to receive your free consultation with a Pradaxa lawsuit attorney.
Updated October 16th, 2012
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
View all: Pharma Drugs & Medical Devices